Oncolytics Biotech® Inc. (NASDAQ: ONCY), announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of primary peritoneal cancers. On Wednesday shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) closed at $1.01.
Exact Sciences Corp. (NASDAQ:EXAS) announced that Aetna, one of the country’s leading health plans, will cover Cologuard under its Medicare Advantage plan, reaching 967,000 members across the country. The three year agreement will go into effect on April 1, 2015. Exact Sciences Corporation (NASDAQ:EXAS) in last trading activity moved up 3.99% to close at $21.90. Company weekly performance is -8.83% while its quarterly performance stands at -7.71%. Exact Sciences Corporation (NASDAQ:EXAS) is -26.93% away from its 52 week high.
On last trading day Knowles Corporation (NYSE:KN) moved up 2.04% to close at $19.54. Its Robert W. Baird upgraded shares of Knowles Corp (NYSE:KN) from a neutral rating to an outperform rating in a research note issued to investors on Friday, TheFlyOnTheWall.com reports. The firm currently has $23.00 price target on the stock, up from their previous price target of $20.00. The analysts noted that the move was a valuation call. volatility for the week is 2.54% while volatility for the month is 4.55%. Knowles Corporation (NYSE:KN) monthly performance is -12.22%.
On 24 February LinkedIn Corporation (NYSE:LNKD) said that it has settled for $1.25 million a lawsuit that alleges the social network didn’t do enough to protect the passwords and personal information of its paying users. LinkedIn Corporation (NYSE:LNKD) has 0.40% insider ownership while its institutional ownership stands at 95.10%. In last trading activity company’s stock closed at $265.23.
On last trading day Micrel Inc. (NASDAQ:MCRL) moved up 0.13% to close at $14.86. Its volatility for the week is 2.63% while volatility for the month is 2.31%. MCRL’s sales growth for past 5 years was 2.50% and its EPS growth for past 5 years was -1.60%. Micrel Inc. (NASDAQ:MCRL) monthly performance is 5.92%.